Annual Non Current Assets
$8.04 M
-$1.19 M-12.93%
30 September 2022
Summary:
NeuBase Therapeutics annual long term assets is currently $8.04 million, with the most recent change of -$1.19 million (-12.93%) on 30 September 2022. During the last 3 years, it has fallen by -$1.19 million (-12.93%).NBSE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$5.27 M
-$1.55 M-22.69%
30 September 2023
Summary:
NeuBase Therapeutics quarterly long term assets is currently $5.27 million, with the most recent change of -$1.55 million (-22.69%) on 30 September 2023.NBSE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -12.9% | -43.0% |
| 5 y5 years | +435.5% | +250.8% |
NBSE Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -56.9% | -74.2% |
NeuBase Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $5.27 M(-22.7%) |
| June 2023 | - | $6.82 M(-5.9%) |
| Mar 2023 | - | $7.25 M(-4.9%) |
| Dec 2022 | - | $7.62 M(-5.3%) |
| Sept 2022 | $24.65 M(-55.1%) | $8.04 M(-3.9%) |
| June 2022 | - | $8.38 M(-2.5%) |
| Mar 2022 | - | $8.59 M(+0.3%) |
| Dec 2021 | - | $8.56 M(-7.3%) |
| Sept 2021 | $54.93 M(+67.4%) | $9.24 M(+1.5%) |
| June 2021 | - | $9.10 M(+259.3%) |
| Mar 2021 | - | $2.53 M(+30.5%) |
| Dec 2020 | - | $1.94 M(+18.7%) |
| Sept 2020 | $32.81 M(+197.5%) | $1.64 M(+29.1%) |
| June 2020 | - | $1.27 M(+1.6%) |
| Mar 2020 | - | $1.25 M(-7.3%) |
| Dec 2019 | - | $1.34 M(-10.5%) |
| Sept 2019 | $11.03 M(+4318.8%) | $1.50 M(-78.9%) |
| June 2019 | - | $7.13 M(-2.3%) |
| Mar 2019 | - | $7.30 M(-2.1%) |
| Dec 2018 | - | $7.46 M(>+9900.0%) |
| Sept 2018 | $249.60 K(-98.1%) | $0.00(-100.0%) |
| June 2018 | - | $13.22 M(-2.4%) |
| Mar 2018 | - | $13.55 M(-7.2%) |
| Dec 2017 | - | $14.61 M(-2.0%) |
| Sept 2017 | $13.02 M(-2.0%) | $14.90 M(-2.0%) |
| June 2017 | - | $15.20 M(-2.4%) |
| Mar 2017 | - | $15.57 M(-1.8%) |
| Dec 2016 | - | $15.87 M(-1.8%) |
| Sept 2016 | $13.29 M(-54.2%) | $16.16 M(-1.8%) |
| June 2016 | - | $16.46 M(-1.8%) |
| Mar 2016 | - | $16.75 M(-1.7%) |
| Dec 2015 | - | $17.05 M(-1.7%) |
| Sept 2015 | $29.04 M(+117.4%) | $17.33 M(-1.7%) |
| June 2015 | - | $17.63 M(-1.2%) |
| Mar 2015 | - | $17.85 M(-2.8%) |
| Dec 2014 | - | $18.36 M(-1.7%) |
| Sept 2014 | $13.35 M | $18.67 M(-8.7%) |
| June 2014 | - | $20.46 M(+3752.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $531.00 K(-4.0%) |
| Dec 2013 | - | $553.10 K(-3.9%) |
| Sept 2013 | $5.17 M(+81.3%) | $575.60 K(-4.3%) |
| June 2013 | - | $601.30 K(-3.5%) |
| Mar 2013 | - | $623.20 K(-3.3%) |
| Dec 2012 | - | $644.80 K(-3.3%) |
| Sept 2012 | $2.85 M(+312.1%) | $666.80 K(-3.2%) |
| June 2012 | - | $688.70 K(-3.1%) |
| Mar 2012 | - | $710.50 K(-3.0%) |
| Dec 2011 | - | $732.40 K(+1.6%) |
| Sept 2011 | $691.80 K(+13.9%) | $721.10 K(-2.8%) |
| June 2011 | - | $742.10 K(-2.7%) |
| Mar 2011 | - | $762.90 K(-2.7%) |
| Dec 2010 | - | $783.70 K(-2.6%) |
| Sept 2010 | $607.50 K(+41.1%) | $804.60 K(+0.6%) |
| June 2010 | - | $800.00 K(0.0%) |
| Mar 2010 | - | $800.00 K(-9.6%) |
| Dec 2009 | - | $885.00 K(+10.6%) |
| Sept 2009 | $430.60 K(+349.5%) | $800.00 K(+15.4%) |
| June 2009 | - | $693.00 K(0.0%) |
| Mar 2009 | - | $693.00 K(+715.3%) |
| Dec 2008 | - | $85.00 K(0.0%) |
| Sept 2008 | $95.80 K(-51.4%) | $85.00 K(0.0%) |
| June 2008 | - | $85.00 K(0.0%) |
| Mar 2008 | - | $85.00 K(-83.2%) |
| Sept 2007 | $197.00 K(-47.1%) | $505.00 K(+642.6%) |
| June 2007 | - | $68.00 K(-84.1%) |
| Mar 2007 | - | $427.00 K(-18.4%) |
| Dec 2006 | $372.30 K(+823.8%) | - |
| Mar 2006 | - | $523.00 K(-2.1%) |
| Dec 2005 | $40.30 K(-86.7%) | $534.30 K(-2.6%) |
| Sept 2005 | - | $548.80 K(+18.8%) |
| June 2005 | - | $462.10 K(+124.3%) |
| Mar 2005 | - | $206.00 K(+1.5%) |
| Dec 2004 | $302.30 K(+4.8%) | $202.90 K(+3.0%) |
| Sept 2004 | - | $197.00 K(+15.1%) |
| June 2004 | - | $171.10 K(-4.6%) |
| Mar 2004 | - | $179.40 K |
| Dec 2003 | $288.50 K | - |
FAQ
- What is NeuBase Therapeutics annual long term assets?
- What is the all time high annual non current assets for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for NeuBase Therapeutics?
What is NeuBase Therapeutics annual long term assets?
The current annual non current assets of NBSE is $8.04 M
What is the all time high annual non current assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual long term assets is $18.67 M
What is NeuBase Therapeutics quarterly long term assets?
The current quarterly non current assets of NBSE is $5.27 M
What is the all time high quarterly non current assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly long term assets is $20.46 M